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ABSTRACT
Introduction:Tuberculous meningitis (TBM) is the most common and belligerent form of CNS TB.Prompt definitive
diagnosis of TBM is arduous due to tedious microbiological procedures. This study was conducted to evaluate the
neuroradiological findings in patients with TBM as a modality forearly diagnoses and predicting prognosis.
Materials and methods: A successive series of 100 patients diagnosed with TBM admitted to the PIMS neurology
ward were studied between March 2013 and April 2014. Cranial imaging results were obtained by non-contrast
enhanced CT brain (NECT) and MRI (magnetic resonance imaging) brain with contrast. MRC staging on admission and
in-hospital mortality were recorded.Results: The mean age was 34.86 ± 1.76 years with a female preponderance
(55%, 55 out of 100). On admission, 72% were in MRC stages II or III. The in-hospital mortality was 16%. NECT was
obtained in all the patients and was abnormal in 67% of the patients with hydrocephalus (58%), edema cerebral (24%)
and infarcts (5%) being the commonestfindings.CT infarct had the highest mortality rate of 60%. MRI was obtained in
61% of the patients and was abnormal in 88.5% of these cases. Hydrocephalus (61%), tuberculomas (54%),
leptomeningeal involvement (46%) and infarcts (13%) were the most frequent radiological signs on MRI. Mortality was
significantly associated with infarcts but not with tuberculomas.Conclusion: Neuroimaging techniques are a handy
tool in the early diagnosis of TBM. MRI is particularly helpful in defining findings such as infarcts and tuberculomas and
in predicting mortality and morbidity.
KEYWORDS: CNS TB; TBM; NECT; MRI brain; prognosis; mortality; MRC staging.
INTRODUCTION

bacillus smear or culture.[4,5, 6]Cerebrospinal fluid (CSF)
biochemistry and cell count is helpful for diagnosis and
requires clinical correlation.[7]CSF culture for
mycobacterium tuberculosis remains the gold standard
for diagnosing CNS TB. However it is a time-consuming
investigation with poor sensitivity and can be negative
in 15-75% of cases.[6]
Studies have suggested a
better yield with serial larger volume taps, which again
is cumbersome. [8] Neuroimaging studies, both CT scan
and MRI are of vital importance in the early diagnosis of
CNS tuberculosis and may prevent excessive morbidity
and mortality due to treatment delay and subsequent
neurological sequelae. [9]Contrast enhanced MR
imaging is generally considered as the modality of
choice in the assessment of patients with CNS
tuberculosis. However, its efficacy and utility has not
been fully evaluated in clinical trials. The specific
findings of the disease on imaging studies are
tuberculomas,
basal
meningitis,
meningeal
enhancement, hydrocephalus, brain abscess, cerebral
edema, calcification and infarcts. [9-11]These

Tuberculous meningitis (TBM) is the most common yet
belligerent form of CNS tuberculosis with invasion and
involvement of the meninges and the underlying brain
parenchyma.[1] It constitutes 1% of all cases of TB with
a case fatality rate of almost 100% in untreated cases,
as the disease is complicated by hydrocephalus, brain
edema, infarction, tuberculomas and brain abscess, to
name a few.[2] The global disease burden has a
considerable magnitude with approximately 9 million
affected in 2013 with an estimated mortality of 1.5
million.[3] A delay in treatment precludes a precarious
outcome, as the disease stage at which antimicrobial
therapy is started is the single most important predictor
of prognosis.[4] Early and definitive diagnosis of TBM is
difficult due to the subacute presentation with
nonspecific clinical manifestations. The diagnosis of
TBM cannot be confirmed or excluded on the basis of
clinical findings. Microbiology is time consuming and
has a low sensitivity in TBM whether it is acid-fast
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characteristic findings can be more accurately
identified by MRI brain which can be useful for early
diagnosis, prognosis and also for follow-up.[12-14] MRI
brain provides a better view of infratentorial lesions.
Modalities like diffusion-weighted imaging (DWI) and
apparent diffusion coefficient (ADC) sequences aid in
screening the subtle, early cerebral changes of infarcts
complicating TBM.[15] However, data regarding the
diagnostic sensitivity and specificity and prognostic
implications of neuroimaging in TBM are limited. This
study was carried out to evaluate the diagnostic and
prognostic value of neuroimaging techniques i.e. CT
brain and MRI brain in TBM, in terms of predicting
disease morbidity and mortality.

of other organisms on lab analyses, patients with
clinical features and CSF typical of pyogenic meningitis
(predominant neutrophilic leukocytosis) on routine
examination, patients with CNS malignancy and
pregnancy. BMRC (British Medical Research Council
Scale) staging of TBM was done for all patients at the
time of admission in addition to detailed history and
examination. MRC was used as the scale to assess
disease severity and morbidity in this study.
An urgent NECT brain scan was done before lumbar
puncture for all the patients on admission and reported
by radiologist. An MRI scan of the brain with contrast,
DWI and ADC sequences was performed during hospital
stay or on out-patient basis for all the available patients
and subsequently reported by a radiologist within a
week. These scans were evaluated for various
radiological manifestations of TBM like hydrocephalus,
cerebral edema, infarct and tuberculomas. In-hospital
outcome in terms of mortality was recorded for all
patients during 2 weeks of hospital stay. MRC at the
time of admission and in-hospital mortality were used
to define prognosis. All patients were treated with
antitubercular therapy and steroids and monitored for
clinical improvement.

MATERIALS AND METHODS
This was a single-center, prospective, observational,
descriptive study conducted via consecutive,
non-purposeful sampling at the Department of
Neurology, PIMS hospital, Islamabad over 13 months
i.e. from 15th March 2013 to 14th April, 2014 after
approval from the hospital ethical committee. A series
of 100 patients diagnosed with tuberculous meningitis
admitted in succession to the neurology ward were
enrolled without delay. This study was an independent
project of the department and was not funded by any
pharmaceutical organization. Informed consent was
obtained from all patients (and in case of obtunded or
comatosed patients from their next of kin). Patients
above the age of 12 years with diagnosis of TB
meningitis were included in the study. The diagnosis of
TBM was established on the basis of clinical and lab
parameters as well as a favorable, therapeutic
response to antitubercular therapy at 2 weeks. The
clinical parameters included any two of: fever,
constitutional symptoms, symptoms and signs of
meningeal irritation and altered mental state for more
than 2 weeks. The lab parameter employed in this
study was a CSF biochemistry and cell count typical of
TBM i.e. a lymphocytic-predominant pleocytosis
(100-500 WBCs with lymphocytic-predominance),
hypoglycorrhachia (<60% of blood glucose) and high
protein concentration (>45mg/dl).[4]CSF analysis was
performed using SysmexXN/1000 2013 analyzer. CSF
acid-fast bacillus smear was performed in all cases but
wasn’t employed as diagnostic tool. CSF for AFB
culture was sent for most of the patients but that data
was not included in this trial as the aim of this study
was to validate the diagnostic utility of neuroradiology
and not microbiology. Key exclusion criteria included
patients with CSF positive for Gram staining or culture
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STATISTICAL ANALYSIS
Data was collected on standard performa and was
analyzed by using the statistical software SPSS version
17 (SPSS Inc. Chicago, IL USA). Discrete variables
were listed as counts or percentages and continuous
variables were listed as means ± SD. Chi-square test
was used for univariate analysis of categorical
variables.Multivariate analysis was done using stepwise
forward logistic regression. Significance was set at
p<0.05. Results were expressed in tabulated form or
graphically.
RESULTS
The baseline characteristics of study population are
shown in Table I. The mean age was 34.86 ± 1.75
years ranging from 13 -80 years with a female
preponderance (55; 55%). The female to male ratio
was 1.25:1. At the time of admission, 28% were in
MRC stage I, 58% were in MRC stage II while 14% were
in stage III. 16% patients expired within 2 weeks of
hospital stay and 84% survived. The mean age of the
patients who had expired was 34.87 ± 2.21 years with
a female preponderance. The baseline characteristics
andtheirgender based distribution is mentioned in
Table I
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Table I: Baseline characteristics at admission and gender based distribution
Variables

Total n %

Gender Mean ± SD (range)/ n (%)
Male

Mean Age (yrs)
MRC Stage

Mortality

34.86±1.75

Female

39.64±1.90 (16-80)

30.94±1.53 (13-80)

MRC I

28 (28)

12 (12)

16 (16)

MRC II

58 (58)

28 (28)

30 (30)

MRC III

14 (14)

5 (5)

9 (9)

Died

16 (16)

5 (5)

11 (11)

Survived

84 (84

40 (40)

44 (44)

NECT was obtained in all the patients and was
(61%),
tuberculomas
(54%),
leptomeningeal
abnormal in 67%. The most common CT findings were
enhancement (46%) and infarcts (13%) were the most
hydrocephalus (58%), cerebral edema (24%) and
frequent findings; summarized in Table II and illustrated
infarcts (5%); summarized in Table II.Some patients
in Figure I.Some patients had a combination of the
had a combination of the findings. On univariate
findings. On univariate analysis patients with normal
analysis patients with normal CT weremostlyin MRC
MRI mostly were in MRC stage 1 or 2 (p= 0.04)
stage 1 or 2 (p= 0.00) whereas those with infarction
whereas those with infarction were mostly in stage 2 or
were mostly in stage 3 (p= 0.00). Those with edema
3 (p= 0.00). Those with leptomeningeal enhancement
and hydrocephalus were mostly in stage 2 (p=00 for
were mostly in stage 2 (p=00). Univariate analysis did
both).
Similarly
patients
with
abnormal
CT
brain
had
a
not revealAlarm
hydrocephalus
or tuberculomas
to have
Seri Indication
Surgical
IONMFollow
Outcome
higher mortality as compared to those with a normal
significant association with MRC stage (p.0.05 for
al (p=0.01). CT infarct had theprocedure
to with abnormal
Up MRI brain had higher
NECT
highest mortality Modality
both). Patients
(60%;
as compared to those with a normal MRI
No p= 0.00) signifying a higher chance of mortality Usedmortality surgeon
with infarct.Idiopathic
This was followed
(33%; p = SSEP (p=0.04).No
MRI
infarct had
the highest mortality
scoliosisby edema
posterior
change
Lost
----- (50%;
01
0.00) and hydrocephalus (24.0%;p=
0.00). (post:tibial)
p= 0.00)in
signifying
spinal
lat: or a higher chance of mortality with
Multivariate analysis however showedfusion(PSF)
only edema to be
infarct. This
followed by leptomeningeal
Amp: was
of
significantly associated with a higher
MRC
stage
but
enhancement
(21%;
p
=
0.03) (Figure II). Multivariate
and
P-37 wave
none of the CT findings were significantly
associated
analysis
however
showed
none of the findings to be
instrumentatio
with mortality(p>0.05 for all) (Table II).
significantly associated with a higher MRC stage
n
MRI was obtained in 61%and was abnormal in 88.5%
(p>0.05 for all).Multivariate analysis for mortality
Tethered cord synd: Laminectomy SSEP
No change Lost
-----of02
these cases. MRI brain could not be done in 39% of
showed infarct to be significantly
associated
with higher
and
filum
(post:tibial)
in
lat:
or
the patients. Amongthese patients, hydrocephalus
chance of death(p=.00) (Table II) (Figure II)

terminale or

Amp: of

tether
P-37 wave
Table II: Univariate and multivariate other
analysis
for CT and MRI brain findings
transection
Morbidity
scoliosis
posterior
SSEP
03
spinal
(post:tibial)
Neuroimaging
MR MR
fusion(PSF)
Variables
CI
C II
III
and
n
n
n
Multivariat
instrumentatio
OR
ep
ep
(%)
(%)
(%)
n
CT Brain Right
findingSpastic
Right
Free-running
04
Yes
16
16
hemiparesis
Selective
and Trigged1 (1)
(16) (16)
12.3
motor
post
EMG of
Normal
0.00*
0.00*
tibialfasiculoto
right tibial
8
12
42
13
No
my
nerve.
(12) (42) (13)

Mortality
No change No
in lat:Survive
or
deficit
Died
Amp: ofd
P-37 wave noted
n

(%)

n (%)

OR

good

Univariat Multivariat
ep
ep

No
No
good
neurotonic
1 (1) 32 (32) deficit
discharges
6.16 0.01*
0.87
and intact noted
15
52 (52)
CMAP
(15)
response.
Yes
0 (0) right
1 (1) 4 (4)
3No
(3) 2 (2) No
Post
trumatic
Exploration
Free-running
good
05I S T A N J O U R N A L O F N E U R O L O G I C A 19.1
1 (2) APR - JUN 2016
1
.
L
P A KInfarct
L S C I E N 0.00*
CES
O
V
0
7
0.97
0.05
Brachial plexopathy and
and Triggedneurotonic 7.58 0.00*
deficit
6
28
57
10
13
neurotizationo EMG
discharges
No
82 982)
(28)

(57)

(10)

(13)

MR
CI

MR
C II

III

n
(%)

n
(%)

n
(%)

16
(16)

16
(16)

1 (1)

12
No
(12)

42
(42)

13
(13)

Neuroimaging
Variables

Died
OR

Multivariat

n

ep

ep

(%)

0.00*

0.00*

Survive
d

n (%)

OR

Univariat Multivariat
ep
ep

CT Brain finding
Yes
Normal

Yes
Infarct

0 (0) 1 (1) 4 (4)

28
No
(28)

57
(57)

10
(10)

Yes

1 (1)

16
(16)

7 (7)

27
No
(27)

42
(42)

7 (7)

Yes 11
(11)

34
(34)

13
(13)

Hydrocephal
17
No
us
(17)

24
(24)

1 (1)

Edema

12.3
8

19.1
6

12.0
0

11.0
1

1 (1) 32 (32)

0.00*

0.97

6.16

0.01*

0.87

7.58

0.00*

0.05

7.05

0.00*

0.06

6.80

0.00*

0.20

3.56
7
(11.4) 47 (77)

0.04*

0.00*

15
(15)

52 (52)

3 (3)

2 (2)

13
(13)

82 982)

8 (8) 16 (16)
0.00*

0.02*
8 (8) 68 (68)

0.00*

0.98

14
(14)

44 (44)

2(2)

40 (40)

MRI Brain finding
Yes 5
3
0 (0)
(8.1) (4.9)
Normal

13
36
No (21.3)
(59)

5
(8.1)

0 (0) 8 (13.1)
9.96

0.04*

0.97

Yes
4
4
Intramedullary
Laminectomy SSEP
0 (0)
thoracic spinal (6.5)
tumor (6.5)
and tumor
(post:tibia
Infarct
18.98 0.00*l)
0.99
18
34
resection
1

4
No
change
4 (6.5) Lost
----(6.5)
in lat: or
12.5
0.00*
0.00*
Amp:of
5
3
50
No (29.5) (55.7)
P-37 wave
(1.6)
(4.9) (81.9)
Tethered
cord
Laminectomy
FreeNo
No deficit good
10
synd:+meningomyelo
and
running
neurotonic
9
23
noted
5
32
cle Yes (14.7) (37.7) 5tether
and
discharges
(8.1)
(8.1
transection
Triggedand) (52.4)
Hydrocephal
0.82
and 7.52
tumor 0.11 EMG0.98
identifyﬁlu 3.03 0.22
us
9
16
resection
m
2
23
No (14.7) (26.2) 0 (0)
terminale
or
(3.2
) (37.7)
other tether
before
Yes 5
5
6
Basal
18
22 (36)
transection
meningeal
(8.1) (29.5) (8.1) 10.63 0.03*
(9.8)
0.97
6.59 0.03*
0.10
Acoustic neuroma
transtemporal
FreeNo
Houseneurodefic
enhancement
11
13
21
approach
running
No
0 (0)
1 neurotonic
(1
.6) 33 (54) brackman it
(21.3) (34.4
)
and
discharges
7
23
3
29 n grade
Triggedand
Yes
4 (6.5
) intact
(11.4
) (37.7
) (4.9)
(47.5
EMG of
CMAP ) II->III
Tuberculomas
7.00 0.13
0.98
2.72
0.25
0.78
CN VII,V
response26
11
16
2
No
3 (4.9
)
innervated
(18) (26.2
) (3.2)
(42.6)
muscles.
scoliosis
posterior
SSEP
No change No deficit good
12
spinal
(post:tibial)
in lat: or
noted
fusion(PSF)
Amp: of
and
P-37 wave
instrumentatio
P A K I S T A N J O U R N A L O F N E U R O L O GnI C A L S C I E N C E S
VOL. 11 (2) APR - JUN 2016
08
Tethered cord synd:
Laminectomy FreeNo
No deficit good
13

09

DISCUSSION
TBM is the most common cause of chronic meningitis
caused by mycobacterium tuberculosis in the
developing countries and is a major public health
problem due to its permanent neurological sequelae
and mortality. [4] It is the most common and severe form
of central nervous system tuberculosis with invasion
and involvement of the meninges and the underlying
brain parenchyma. The diagnosis of TBM is elusive and
high index of suspicion is necessary for early diagnoses.
The definitive diagnosis of TBM is dependent on
microbiological testing by demonstrating M.
tuberculosis on smear as AFB or culture of the CSF.
[16,17]
CSF acid fast bacillus has a low sensitivity of
20-40%.[18]CSF culture is a time-consuming procedure.
Moreover, CSF culture can be negative in 15-75% of
cases.[6] Treatment delay is often associated with high
fatality therefore early recognition is of paramount
importance as the clinical outcome depends upon the
stage at which therapy is initiated.[2,17] Current
antituberculous drugs are highly effective when
treatment commences early, before the onset of
complications.The typical neuroradiological findings of
TBM appear due to the pathophysiology of TBM which
can aid in the diagnosis of TBM.[19,20]However, the
diagnostic value hasn’t been fully validated in studies.
Moreover, data on the utility of neuroradiology in
predicting the outcome of TBM is even more
limited.Cranial imaging is useful in diagnosing TBM,
predicting its complications and also has a prognostic
value.[14,21-25] Some studies comparing CT to MRI have
indicated MRI as a superior diagnostic imaging
modality.[23-25] In this study, NECT brain was obtained in
all the patients prior to lumbar puncture, due to easy
availability and quick completion. CT brain was
abnormal in 67% of the patients. In a review of 289
patients published in the year 2000 CT brain was found
to be abnormal in 87% cases.[26] This difference in
radiological yield may be attributed to the fact that they
performed both NECT and CT with contrast while we
only got the former done. MRI brain with contrast with
DWI and ADC was done in 61% of the patients. Out of
the 61 patients in whom MRI scans were done 88.5%
had radiological findings. This finding is almost
comparable to a study in which MRI brain revealed
findings in 90% cases.[27] MRI showed even more
findings in cases where CT scan results were suspicious
or normal especially in case of meningeal
enhancement or tuberculomas as seen in earlier
studies.[27] In this study 10 patients had normal CT
scans of the brain, while the MRI scans of these

Figure I: MRI Brain in CNS TB
Figure I: MRI Brain in CNS TB: A: Hydrocephalus as
shown in MRI brain of one of our patients (No.22)
depicted by dilated anterior and posterior horns of
lateral ventricles (arrow heads),B: DWI MRI Brain
showing restricted diffusion in right sided basal ganglia
and thalamus regions in one of our patients (No.35)
(arrow head in circle), C: Schematic of MRI Brain T1WI
with contrast studded with multiple small tuberculomas
(arrow heads)(No.72)D: MRI Brain T1WI with contrast
showing basal meningeal enhancement (thick arrow
head within circle) in one of our patients (No.83).

Figure II: MRI Brain findings and distribution of
mortality: vertical double capped lines show 1 SD.
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patients revealed abnormal findings. MRI with contrast
has higher efficacy for detecting tuberculomas, basal
enhancement and infarction in TBM. Majority of the
patients in this study presented in MRC stage 2 which
is comparable with most of other studies. [28]The
delayed presentation of TBM may be attributed to the
poor socioeconomic background and low literacy rate of
most of our patients, especially those from remote rural
areas who do not seek proper medical assistance until
the terminal stages of the disease. However, this just a
theoretical assumption and requires proper statistical
validation. Ischemia/infarcts were observed in 13% of
the patients. Previous studies reported the incidence of
infarction in TBM as ranging from 13% to
53%.[29-31]Those patients who had infarcts on CT or MRI
brain had greater morbidity reflected by MRC stage of
mostly 3. Almost 60% mortality was seen in these
patients. Infarcts have been shown to be associated
with poor outcome in TBM as shown Wasay et al in their
study.[14] MR scans especially DWI sequences were
superior in detecting infarcts. The mean age of patients
with TBM complicated by infarcts was 35.12 ± 2.18
years (75% males) in our study which was much lower
than the mean of age of similar patients in their study
i.e. 57 ± 17.6 (56.7% males). They attributed it to
Ischemic heart disease while we propose an infection
relatedvasculitis as the etiology which tends to be more
common in younger patients. This however, needs
validation in a separate study designed to evaluate
patients of TBM with infarcts alone.Tuberculomas were
detected in 33 of the patients in this study (54%).
Tuberculomas are common forms of CNS TB and result
from parenchymal rich foci.[10]Tuberculomas are
frequently multiple. [10,26,27]In this study 82.4% of these
33 patients had multiple tuberculomas. Patients with
tuberculomas were mostly in MRC stage 2. However,
mortality was not statistically significant. This is in
contrast to older studies;[32] but corresponds to the
results of the study by Wasay et al.[14] Hydrocephalus is
a common complication of TBM, and was seen in 61%
cases in this study which is in accordance with most of
the other studies.[32,33]The reported frequency of
hydrocephalus varies from 12% to 77% in patients with
TBM in various case series.[16,32-34] Patients with
hydrocephalus were mostly in MRC stage 2 and had a
higher mortality compared to those with normal
neuroimaging. In conclusion, patients with infarcts had
a worse outcome as compared to those with
hydrocephalus or tuberculomas.MRI scans provided
additional findings such as tuberculomas and infarcts
not identified on CT. This might help in modifying drug
regime or duration of therapy by follow up scans and
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comparing scans for resolution of findings. This study
was limited by the fact that patients were screened only
at the commencement of therapy, and there was no set
protocol for follow up of patients who develop these
complications during the course of treatment or
whether initiating prompt therapy conferred a better
outcome as we did not study end of treatment
outcomes. Neuroradiological findings such as infarcts,
tuberculoma or hydrocephalus, are helpful for the
diagnosis of TBM in the early stages before a
microbiological diagnosis is established.[35-37] MRI and
CT scanning are also critical in predicting the outcome
and in evaluating the complications of the disease as
shown in the study by Wasay et al.[14] Therefore, MRI
brain with contrast and DWI sequences should be
performed for all patients in the early stage of the
disease to detect specific signs related with poor
outcome. It may reveal specific radiological findings
associated with TBM which contribute to diagnostic
certainty.
CONCLUSION
Neuroimaging techniques are a handy tool in the early
diagnosis of TBM. MRI is particularly helpful in defining
findings such as infarcts and tuberculomas and in
predicting mortality and morbidity.
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